Full-Time
Registered Nurse Clinical Manager
Home Health
BrightSpring Health Services
10,001+ employees
Home-based health services and pharmacy solutions
No salary listed
Brunswick, GA, USA
In Person
Bachelor's
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to BrightSpring Health Services
See people who can refer or advise you
- Be a licensed Registered Nurse in good standing and currently licensed by the state.
- Have less than two years of clinical experience and at least one year in a related management or supervisory role in home health care.
- Hold current CPR certification.
- Meet all agency requirements for pre-employment as required by the company and state regulations.
- Be able to use company documentation systems.
- Be able to communicate verbally and in writing with all levels of personnel, both internal and external to the company.
- Be able to work independently and as part of a team.
- Be capable of working responsibly with highly confidential information.
- Conduct or participate in quarterly quality improvement meetings, review pertinent available data, identify trends, and oversee implementation of improvement plans.
- Collaborate with the Branch Director to implement quality improvement activities and corrective action plans.
- Oversee and respond to external and internal surveys and audits within the assigned area relating to quality of care and clinically related key performance indicators, in collaboration with operations leadership.
- Complete documentation and chart reviews to identify variances in standardized care and care processes and areas for improved patient-care and organizational performance.
- Hold case conferences to ensure oversight of care, coordination of services, and compliance with standards.
- Facilitate performance improvement action plans based on available data, including survey results, Quality Assessment and Performance Improvement reviews, and clinical record reviews.
- Communicate job expectations; plan, monitor, and appraise job results; coach, counsel, and discipline employees; and develop, coordinate, and enforce systems, policies, procedures, and productivity standards.
- Ensure assigned staff are evaluated fairly and timely in accordance with company performance evaluation procedures.
- A bachelor's degree in Nursing from an accredited school of nursing is preferred.
- Experience with Oasis and Homecare Home Base is preferred.
BrightSpring Health Services delivers home and community-based health services for people with complex or chronic needs, organized into two segments: Pharmacy and Provider. The Pharmacy segment provides specialty, infusion, and community pharmacy services to patients with complex conditions. The Provider segment offers behavioral health, home health, hospice care, and services for individuals with intellectual and developmental disabilities. The company runs an integrated care model through a network of pharmacies and providers to support a continuum of care that includes clinical services, care coordination, and in-home support. Revenue comes from Medicare, Medicaid, and private insurance, reflecting reimbursement across public and private payers. The goal is to coordinate pharmacy and in-home health services to improve access, continuity, and outcomes for patients and to serve managed care organizations with a complete care solution.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Get referred to BrightSpring Health Services
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue rose 23% to $3.87 billion, with EBITDA up 44%.
- Management raised 2026 EBITDA guidance to $820 million–$845 million on July 31, 2026.
- Leverage fell to 2.15x, and S&P and Moody’s upgraded BrightSpring’s credit.
What critics are saying
- IRA pricing cuts reduced Home and Community Pharmacy 8% in Q2 2026.
- Management expects roughly $200 million 2026 IRA pressure, crushing pharmacy margin leverage.
- PharMerica’s breach settlement and security spending drain cash during Amedisys integration.
What makes BrightSpring Health Services unique
- BrightSpring combines specialty pharmacy with home-based provider services across complex chronic care.
- Its 2026 portfolio reached 153 ultra-narrow drugs, strengthening limited-distribution access advantages.
- Amedisys and LHC branches deepen BrightSpring’s local density in home health and hospice.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↓ -10%1 year growth
↓ -10%2 year growth
↓ -10%BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.
Two companies leverage profitability to outpace competitors, whilst another faces headwinds, according to StockStory's analysis. Primoris, which builds and maintains infrastructure in utility, energy, and civil construction sectors, struggles with a low gross margin of 10.3% reflecting high production costs. The company has seen falling earnings per share over two years and weak free cash flow margin of 2.2% over five years. BrightSpring Health Services, offering home health care and pharmacy services, has posted 23.9% annual revenue growth over two years. Its revenue base of $14.37 billion provides economies of scale. Pfizer's massive $63.7 billion revenue base gives it significant negotiating power. The pharmaceutical giant's adjusted operating margin expanded by 18.5 percentage points over two years, whilst delivering a 17.5% return on capital.
BrightSpring Health Services exceeded Wall Street expectations in Q2, delivering revenue of $3.87 billion and adjusted earnings per share of $0.45, beating analyst estimates by 5.9% and 13% respectively. The company's Specialty and Infusion pharmacy business drove growth, with revenue up 30% and script growth of 31% year-over-year. CEO Jon Rousseau attributed the performance to new limited distribution drug launches and broad-based volume growth. However, segments like Home and Community Pharmacy faced challenges from customer exits and regulatory headwinds. The company raised its full-year revenue guidance to $15.26 billion at the midpoint, up 1.9% from previous guidance. Operating margin improved to 3.4%, compared to 1.5% in the prior-year quarter. Despite the strong results, the market reacted negatively, reflecting concerns about underlying business headwinds.
Micron Technology, BrightSpring Health Services, and Custom Truck One Source have emerged as standout profitable stocks based on strong net income ratios and growth prospects. The selection criteria included a Zacks Rank of #1, trailing 12-month sales and net income growth exceeding industry averages, and a net income ratio higher than the industry standard. Micron Technology, a global memory and storage provider, shows particularly impressive metrics with a 12-month net profit margin of 55.9%. The company's expected earnings growth rate for the current year stands at 791%. The screening process, using the Zacks Research Wizard, filtered more than 7,685 stocks down to just 13 that met all criteria. The net income ratio helps investors assess a company's ability to cover both operating and non-operating expenses with revenues.
BrightSpring Health Services shares fell 17.5% after reporting second-quarter results, despite beating expectations. The healthcare services provider posted revenue of $3.87 billion, up 23% year-on-year, whilst non-GAAP profit reached $0.45 per share, exceeding forecasts. The company also raised its full-year guidance. However, investors responded negatively in what appeared to be a "sell-the-news" reaction. The sell-off may stem from valuation concerns and stagnant profit margins despite rising sales, raising questions about the company's cost structure. The stock has experienced 18 movements greater than 5% over the past year. At $59.71 per share, BrightSpring trades 18.1% below its 52-week high of $72.91 from July, though it remains up 55.5% year-to-date.